FDA Recommends Pause In Use Of Johnson & Johnson's COVID-19 Vaccine On Blood Clot Concerns

FDA and the Centers for Disease Control and Prevention are recommending a pause in the use of Johnson & Johnson's COVID-19 vaccine, the agencies said in a Tuesday statement, sending the drugmaker's stock lower in premarket trading.